Diego A. Díaz García: Stereotactic Radiosurgery in Oligometastatic Brain Disease
Diego A. Díaz García, Medical Oncologist , CEO and Founder at CánCare, shared on X:
“Stereotactic radiosurgery (SRS) is expanding beyond Oligometastatic brain disease to >4 mets, pre-op use & combos with systemic therapy.
Advances bring promise—and new challenges. A must-read for multidisciplinary teams managing CNS metastases.”
Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care.
Authors: Alireza Mansouri, Ahmad Ozair, Debarati Bhanja, Hannah Wilding, Elad Mashiach, Waqas Haque, Nicholas Mikolajewicz, Leonardo de Macedo Filho, Sean S. Mahase, Mitchell Machtay, Philippe Metellus, Frédéric Dhermain, Jason Sheehan, Douglas Kondziolka, L. Dade Lunsford, Ajay Niranjan, Giuseppe Minniti, Jing Li, Steven N. Kalkanis, Patrick Y. Wen, Rupesh Kotecha, Michael W. McDermott, Chetan Bettegowda, Graeme F. Woodworth, Paul D. Brown, Arjun Sahgal, & Manmeet S. Ahluwalia.
You can Read the Full Article on Journal of Nature Reviews Clinical Oncology.
More posts featuring Diego A. Díaz García.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023